EcoDrugPlus

Toll Like Receptor 4

Ensembl ID : ENSTBEG00000002069
Gene Symbol: TLR4
1 Cross references
127 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSTBEG00000011082
Gene Symbol: TLR8
1 Cross references
200 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSTBEG00000007195
Gene Symbol: TGFBR1
1 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSTBEG00000008402
Gene Symbol: TRPA1
1 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSTBEG00000010083
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSTBEG00000005381
Gene Symbol: TRPV1
1 Cross references
134 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSTBEG00000009527
Gene Symbol: TPH1
1 Cross references
255 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSTBEG00000001671
Gene Symbol: TUBA1B
1 Cross references
92 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSTBEG00000009258
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSTBEG00000000469
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSTBEG00000009499
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSTBEG00000011771
Gene Symbol: TP53
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).